Department of Urology, Martha-Maria Hospital Nuremberg, Nuremberg, Germany.
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Sex Med Rev. 2022 Jul;10(3):451-459. doi: 10.1016/j.sxmr.2021.03.007. Epub 2021 Jul 1.
Penile prosthesis (PP) implantation combined with grafting techniques is indicated in patients with Peyronie's disease (PD) and erectile dysfunction (ED) nonresponsive to medical and conservative treatment that present with residual penile curvature greater than 30°, severe penile deformity or significant penile shortening.
To address the preoperative evaluation, the surgical procedure and the functional outcomes of grafting techniques combined with PP implantation in patients with PD and concomitant ED and to provide future perspectives on the matter.
We performed a systematic review of the literature based on the PRISMA statement (PROSPERO ID: CRD42021224517). Records were identified by searching Medline, Scopus, The Cochrane Library and Web of Science databases as well as sources of gray literature from inception to December 2020. The quality of all included records was assessed based on a modified version of the Newcastle-Ottawa Scale for cohort studies.
A total of 935 patients with a mean age of 59.6 ± 9.2 years from 23 studies were included in this systematic review. All studies reported excellent short- and long-term postoperative results, as well as high satisfaction rates ranging from 80 to 100%. A mean increase of 2.7 ± 1.4 cm in penile length was observed. Among different grafting materials and different types of PP, no significant differences in terms of preoperative, perioperative and postoperative functional outcomes or complications were demonstrated. Still, the operative time was shorter in studies applying the collagen fleece TachoSil.
PP implantation combined with grafting is a safe and highly effective surgical procedure in patients with PD and concomitant ED. All grafting materials provide similar beneficial outcomes, but TachoSil subsequently reduces the operative time and does not require suturing. Still, no definite conclusions can be drawn regarding the superiority of one grafting technique over the other, as randomized clinical trials are lacking. Sokolakis I, Pyrgidis N, Ziegelmann M, et al. Penile Prosthesis Implantation Combined With Grafting Techniques in Patients With Peyronie's Disease and Erectile Dysfunction: A Systematic Review. Sex Med Rev 2022;10:444-452.
阴茎假体(PP)植入术联合移植物技术适用于对药物和保守治疗无反应的伴有勃起功能障碍(ED)的 Peyronie 病(PD)患者,这些患者存在残余阴茎弯曲>30°、严重的阴茎畸形或显著的阴茎缩短。
探讨 PD 合并 ED 患者中 PP 植入术联合移植物技术的术前评估、手术过程和功能结果,并对该领域的未来发展提供展望。
我们根据 PRISMA 声明(PROSPERO ID:CRD42021224517)对文献进行了系统回顾。从 2020 年 12 月开始,通过检索 Medline、Scopus、Cochrane 图书馆和 Web of Science 数据库以及灰色文献来源,确定了记录。根据改良版的 Newcastle-Ottawa 量表对所有纳入的记录进行了质量评估。
本系统评价共纳入 23 项研究的 935 例平均年龄 59.6±9.2 岁的患者。所有研究均报告了短期和长期的术后结果良好,满意度高达 80%~100%。阴茎长度平均增加了 2.7±1.4cm。不同移植物材料和不同类型的 PP 之间,在术前、围手术期和术后功能结果或并发症方面没有显著差异。然而,应用胶原蛋白垫 TachoSil 的研究手术时间更短。
PP 植入术联合移植物技术是 PD 合并 ED 患者安全且非常有效的手术方法。所有移植物材料都提供了相似的有益效果,但 TachoSil 随后减少了手术时间,且不需要缝合。然而,由于缺乏随机临床试验,目前还不能确定一种移植物技术优于另一种。